BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 5173501)

  • 1. [The treatment of hemophilia A with a new antihemophilic fraction "AHF SRK (human)". Comparison with the antihemophilic globulin AHG SRK].
    Duckert F; Müller G; Meili EO
    Schweiz Med Wochenschr; 1971 Dec; 101(50):1831-8. PubMed ID: 5173501
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on the response of patients with classic hemophilia to transfusion with concentrates of antihemophilic factor. A difference in the half-life of antihemophilic factor as measured by procoagulant and immunologic techniques.
    Bennett B; Ratnoff OD
    J Clin Invest; 1972 Oct; 51(10):2593-6. PubMed ID: 4626847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of fraction I for oral surgical procedures in patients with classic hemophilia: report of seven cases.
    Marder VJ; Gamble JW; Shulman NR
    J Oral Surg; 1966 Nov; 24(6):487-99. PubMed ID: 5296941
    [No Abstract]   [Full Text] [Related]  

  • 4. Massive factor-VIII infusion in Haemophiliac with factor-VIII inhibitor, high responder. 1977.
    Brackmann HH; Gormsen J
    Haemophilia; 2010 May; 16(102):2-3. PubMed ID: 20536980
    [No Abstract]   [Full Text] [Related]  

  • 5. [Occurrence of serum hepatitis following the administration of Cohn's fraction I or fibrinogen and antihemophilic globulin (AHG) respectively].
    Fábryová L; Hrubisko M
    Vnitr Lek; 1970 Feb; 16(2):123-6. PubMed ID: 5309309
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of hemophilia A with actor VIII concentrate in urological operations and injuries of the urinary tract].
    Brühl P; Weibbach L; Brackmann HH
    MMW Munch Med Wochenschr; 1975 Mar; 117(10):401-4. PubMed ID: 804604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical application of antihemophilic factor after dental extractions in hemophilic patients.
    Nakajima T; Tomizawa M; Hasegawa S; Ohnishi M; Tokiwa N
    J Oral Surg; 1978 Nov; 36(11):873-7. PubMed ID: 280664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationale and indications for continuous infusion of antihemophilic factor (factor VIII).
    Goldsmith JC
    Blood Coagul Fibrinolysis; 1996 Mar; 7 Suppl 1():S3-6. PubMed ID: 8735789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The treatment of classical hemophilia with factor 8 concentrates.
    Waterbury L; Frenkel EP
    Clin Anesth; 1968; 3():288-97. PubMed ID: 4902367
    [No Abstract]   [Full Text] [Related]  

  • 10. Experimental prophylaxis of severe hemophilia with a factor VIII concentrate.
    Shanbrom E; Thelin GM
    JAMA; 1969 Jun; 208(10):1853-6. PubMed ID: 5818829
    [No Abstract]   [Full Text] [Related]  

  • 11. Antihemophilic factor 8 in hemophilia. Use of concentrates to permit major surgery.
    Mazza JJ; Bowie EJ; Hagedorn AB; Didisheim P; Taswell HF; Peterson LF; Owen CA
    JAMA; 1970 Mar; 211(11):1818-23. PubMed ID: 5467109
    [No Abstract]   [Full Text] [Related]  

  • 12. [Long-term follow-up of consumption of plasma, blood and antihemophilic globulin in patients with hemophilia].
    Pudlák P; Horák J
    Vnitr Lek; 1968 Jan; 15(1):1-8. PubMed ID: 5720983
    [No Abstract]   [Full Text] [Related]  

  • 13. [Spontaneous splenic rupture in a child with hemophilia].
    Gruminskiĭ VS; Grechanyĭ VP
    Vestn Khir Im I I Grek; 1990 Apr; 144(4):69-70. PubMed ID: 2173236
    [No Abstract]   [Full Text] [Related]  

  • 14. [Bleeding times in haemophilia patients treated with lyophilised antihaemophilic globulin (AHG) (author's transl)].
    Sutor AH; Jesdinsky-Buscher CJ
    Dtsch Med Wochenschr; 1976 Nov; 101(47):1715-9. PubMed ID: 991757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Acute appendicitis in sliding hernia in a child with hemophilia].
    Karimov ShN; Tashpulatov SA; Achilov ShA
    Khirurgiia (Mosk); 1989 Nov; (11):137-8. PubMed ID: 2515347
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prophylactic treatment of severe forms of hemophilia A with fraction I (AHG) and PAMBA].
    Gaerisch F; Mey U
    Bibl Haematol; 1967; 27():270-7. PubMed ID: 5302128
    [No Abstract]   [Full Text] [Related]  

  • 17. Experience gained in 35 operations in patients with hemophilia A.
    Ziemski JM; Lopaciuk S; Rudowski W
    Pol Med J; 1971; 10(5):1269-77. PubMed ID: 5133676
    [No Abstract]   [Full Text] [Related]  

  • 18. A new high-potency glycine-precipitated antihemophilic factor (AHF) concentrate. Treatment of classical hemophilia and hemophilia with inhibitors.
    Brinkhous KM; Shanbrom E; Roberts HR; Webster WP; Fekete L; Wagner RH
    JAMA; 1968 Aug; 205(9):613-7. PubMed ID: 5695099
    [No Abstract]   [Full Text] [Related]  

  • 19. [Prevention of hemorrhage in patients with hemophilia].
    Pliushch OP; Rutberg RA; Zakhrova NS; Shefter LI
    Probl Gematol Pereliv Krovi; 1976 Jan; 21(1):11-3. PubMed ID: 1273055
    [No Abstract]   [Full Text] [Related]  

  • 20. [The dosage of antihemophilic globulin, or antihemophilic plasma as well as Cohn's fraction I in factor VIII deficiency].
    Hrubisková K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1970; 93(3):363-8. PubMed ID: 4195283
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.